ArticleJournal of virology2005

Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry.

Atze T Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.